• 2023
  Scarno G, Mazej J, Laffranchi M, Di Censo C, Mattiola I, Candelotti AM, Pietropaolo G, Stabile H, Fionda C, Peruzzi G, Brooks SR, Tsai WL, Mikami Y, Bernardini G, Gismondi A, Sozzani S, Di Santo JP, Vosshenrich CAJ, Diefenbach A, Gadina M, Santoni A, Sciumè G, Divergent roles for STAT4 in shaping differentiation of cytotoxic ILC1 and NK cells during gut inflammation., Proc Natl Acad Sci U S A 2023 Oct; 120(40): e2306761120.
• 2021
  Dupont MSJ, Guillemot V, Campagne P, Serafini N, Marie S, Montagutelli X, Di Santo JP, Vosshenrich CAJ, , Host genetic control of natural killer cell diversity revealed in the Collaborative Cross., Proc Natl Acad Sci U S A 2021 Mar; 118(10): .
• 2019
  Xu W, Cherrier DE, Chea S, Vosshenrich C, Serafini N, Petit M, Liu P, Golub R, Di Santo JP, , An Id2RFP-Reporter Mouse Redefines Innate Lymphoid Cell Precursor Potentials., Immunity 2019 04; 50(4): 1054-1068.e3.
• 2019
  Dupont M, Vosshenrich CAJ, , Conditional Genetic Ablation Mouse Models as a Tool to Study Cancer Immunosurveillance In Vivo., Methods Mol Biol 2019 ; 1884(): 161-176.
• 2017
  Lim AI, Verrier T, Vosshenrich CA, Di Santo JP, , Developmental options and functional plasticity of innate lymphoid cells., Curr Opin Immunol 2017 Feb; 44(): 61-68.
• 2017
  Luque Y, Cathelin D, Vandermeersch S, Xu X, Sohier J, Placier S, Xu-Dubois YC, Louis K, Hertig A, Bories JC, Vasseur F, Campagne F, Di Santo JP, Vosshenrich C, Rondeau E, Mesnard L, Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritis, Kidney Int. 2017 May;91(5):1146-1158.
• 2016
  Chea S, Perchet T, Petit M, Verrier T, Guy-Grand D, Banchi EG, Vosshenrich CA, Di Santo JP, Cumano A, Golub R, Notch signaling in group 3 innate lymphoid cells modulates their plasticity, Sci Signal 2016;9(426):ra45.
• 2016
  Verrier T, Satoh-Takayama N, Serafini N, Marie S, Di Santo JP, Vosshenrich CA, Phenotypic and Functional Plasticity of Murine Intestinal NKp46+ Group 3 Innate Lymphoid Cells, J. Immunol. 2016 Jun;196(11):4731-8.
• 2015
  Serafini N, Vosshenrich CA, Di Santo JP, Transcriptional regulation of innate lymphoid cell fate, Nat. Rev. Immunol. 2015 Jul;15(7):415-28.
• 2015
  Xu W, Domingues RG, Fonseca-Pereira D, Ferreira M, Ribeiro H, Lopez-Lastra S, Motomura Y, Moreira-Santos L, Bihl F, Braud V, Kee B, Brady H, Coles MC, Vosshenrich C, Kubo M, Di Santo JP, Veiga-Fernandes H, , NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors., Cell Rep 2015 Mar; 10(12): 2043-54.
• 2014
  Sepulveda FE, Maschalidi S, Vosshenrich CA, Garrigue A, Kurowska M, Ménasche G, Fischer A, Di Santo JP, de Saint Basile G, A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice, Blood 2015 Feb;125(9):1427-34.
• 2014
  Merzoug LB, Marie S, Satoh-Takayama N, Lesjean S, Albanesi M, Luche H, Fehling HJ, Di Santo JP, Vosshenrich CA, Conditional ablation of NKp46+ cells using a novel Ncr1(greenCre) mouse strain: NK cells are essential for protection against pulmonary B16 metastases, Eur. J. Immunol. 2014 Nov;44(11):3380-91.
• 2014
  Serafini N, Klein Wolterink RG, Satoh-Takayama N, Xu W, Vosshenrich CA, Hendriks RW, Di Santo JP, Gata3 drives development of RORγt+ group 3 innate lymphoid cells, J. Exp. Med. 2014 Feb;211(2):199-208.
• 2013
  Vallese D, Negroni E, Duguez S, Ferry A, Trollet C, Aamiri A, Vosshenrich CA, Füchtbauer EM, Di Santo JP, Vitiello L, Butler-Browne G, Mouly V, The Rag2⁻Il2rb⁻Dmd⁻ mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies, Mol. Ther. 2013 Oct;21(10):1950-7.
• 2013
  Klein Wolterink RG, Serafini N, van Nimwegen M, Vosshenrich CA, de Bruijn MJ, Fonseca Pereira D, Veiga Fernandes H, Hendriks RW, Di Santo JP, Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells, Proc. Natl. Acad. Sci. U.S.A. 2013 Jun;110(25):10240-5.
• 2013
  Vosshenrich CA, Di Santo JP, Developmental programming of natural killer and innate lymphoid cells, Curr. Opin. Immunol. 2013 Apr;25(2):130-8.
• 2011
  Satoh-Takayama N, Lesjean-Pottier S, Sawa S, Vosshenrich CA, Eberl G, Di Santo JP, Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells, Eur. J. Immunol. 2011 Mar;41(3):780-6.
• 2010
  Elkabets M, Ribeiro VS, Dinarello CA, Ostrand-Rosenberg S, Di Santo JP, Apte RN, Vosshenrich CA, IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function, Eur. J. Immunol. 2010 Dec;40(12):3347-57.
• 2010
  Klein Wolterink RG, García-Ojeda ME, Vosshenrich CA, Hendriks RW, Di Santo JP, The intrathymic crossroads of T and NK cell differentiation, Immunol. Rev. 2010 Nov;238(1):126-37.
• 2010
  Ribeiro VS, Hasan M, Wilson A, Boucontet L, Pereira P, Lesjean-Pottier S, Satoh-Takayama N, Di Santo JP, Vosshenrich CA, Cutting edge: Thymic NK cells develop independently from T cell precursors, J. Immunol. 2010 Nov;185(9):4993-7.
• 2010
  Di Santo JP, Vosshenrich CA, Satoh-Takayama N, A ‘natural’ way to provide innate mucosal immunity, Curr. Opin. Immunol. 2010 Aug;22(4):435-41.
• 2010
  Satoh-Takayama N, Lesjean-Pottier S, Vieira P, Sawa S, Eberl G, Vosshenrich CA, Di Santo JP, IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors, J. Exp. Med. 2010 Feb;207(2):273-80.
• 2009
  Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, Renauld JC, Vosshenrich CA, Di Santo JP, The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium, J. Immunol. 2009 Nov;183(10):6579-87.
• 2008
  Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, Thiam K, Cerf-Bensussan N, Mandelboim O, Eberl G, Di Santo JP, Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense, Immunity 2008 Dec;29(6):958-70.
• 2007
  Vosshenrich CA, Lesjean-Pottier S, Hasan M, Richard-Le Goff O, Corcuff E, Mandelboim O, Di Santo JP, CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells, J. Exp. Med. 2007 Oct;204(11):2569-78.
• 2007
  Huntington ND, Vosshenrich CA, Di Santo JP, Developmental pathways that generate natural-killer-cell diversity in mice and humans, Nat. Rev. Immunol. 2007 Sep;7(9):703-14.
• 2006
  Di Santo JP, Vosshenrich CA, Bone marrow versus thymic pathways of natural killer cell development, Immunol. Rev. 2006 Dec;214:35-46.
• 2006
  Vosshenrich CA, García-Ojeda ME, Samson-Villéger SI, Pasqualetto V, Enault L, Richard-Le Goff O, Corcuff E, Guy-Grand D, Rocha B, Cumano A, Rogge L, Ezine S, Di Santo JP, A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127, Nat. Immunol. 2006 Nov;7(11):1217-24.
• 2006
  Liu A, Vosshenrich CA, Lagresle-Peyrou C, Malassis-Seris M, Hue C, Fischer A, Di Santo JP, Cavazzana-Calvo M, Competition within the early B-cell compartment conditions B-cell reconstitution after hematopoietic stem cell transplantation in nonirradiated recipients, Blood 2006 Aug;108(4):1123-8.
• 2005
  Vosshenrich CA, Samson-Villéger SI, Di Santo JP, Distinguishing features of developing natural killer cells, Curr. Opin. Immunol. 2005 Apr;17(2):151-8.
• 2005
  Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, Rosmaraki EE, Di Santo JP, Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo, J. Immunol. 2005 Feb;174(3):1213-21.
• 2004
  Vosshenrich CA, Cumano A, Müller W, Di Santo JP, Vieira P, Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment, Proc. Natl. Acad. Sci. U.S.A. 2004 Jul;101(30):11070-5.
• 2004
  Samson SI, Mémet S, Vosshenrich CA, Colucci F, Richard O, Ndiaye D, Israël A, Di Santo JP, Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation, Blood 2004 Jun;103(12):4573-80.
• 2003
  Samson SI, Richard O, Tavian M, Ranson T, Vosshenrich CA, Colucci F, Buer J, Grosveld F, Godin I, Di Santo JP, GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells, Immunity 2003 Nov;19(5):701-11.
• 2003
  Vosshenrich CA, Cumano A, Müller W, Di Santo JP, Vieira P, Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development, Nat. Immunol. 2003 Aug;4(8):773-9.
• 2003
  Ranson T, Vosshenrich CA, Corcuff E, Richard O, Laloux V, Lehuen A, Di Santo JP, IL-15 availability conditions homeostasis of peripheral natural killer T cells, Proc. Natl. Acad. Sci. U.S.A. 2003 Mar;100(5):2663-8.
• 2003
  Ranson T, Vosshenrich CA, Corcuff E, Richard O, Müller W, Di Santo JP, IL-15 is an essential mediator of peripheral NK-cell homeostasis, Blood 2003 Jun;101(12):4887-93.
• 2002
  Vosshenrich CA, Di Santo JP, Interleukin signaling, Curr. Biol. 2002 Nov;12(22):R760-3.
• 2001
  Montrasio F, Cozzio A, Flechsig E, Rossi D, Klein MA, Rülicke T, Raeber AJ, Vosshenrich CA, Proft J, Aguzzi A, Weissmann C, B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice, Proc. Natl. Acad. Sci. U.S.A. 2001 Mar;98(7):4034-7.
• 2001
  Vosshenrich CA, Di Santo JP, Cytokines: IL-21 joins the gamma(c)-dependent network?, Curr. Biol. 2001 Mar;11(5):R175-7.
• 2000
  Vosshenrich CA, Sharara LI, Guy-Grand D, Rajewsky K, Müller W, Di Santo JP, Common cytokine receptor gamma chain (gammac)-deficient B cells persist in T cell-deficient gammac-mice and respond to a T-independent antigen, Eur. J. Immunol. 2000 Jun;30(6):1614-22.
• 1997
  Sharara LI, Vosshenrich CA, Müller W, DiSanto JP, On the role of the common cytokine receptor gamma chain in B-cell vs. T-cell development, Res. Immunol. 1997 Sep;148(7):449-53.
• 1996
  Betz UA, Vosshenrich CA, Rajewsky K, Müller W, Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination, Curr. Biol. 1996 Oct;6(10):1307-16.